Scotland approves zanubrutinib for relapsed mantle cell lymphoma - PharmaTimes New treatment option now available across all UK nations

#NHSScotland #ScottishMedicinesConsortium #Haematology #BeOneMedicinesUK #BeOne #SMC #SMCrecommendation #zanubrutinib #BRUKINSA #relapsedmantlecelllymphoma #MCL #MCLpatients #refractorymantlecelllymphoma #nonHodgkinlymphoma #LymphomaAction #BeatsonWestofScotlandCancerCentre
zurl.co/lk0uJ